Oncology Nursing News®

Register now to learn about a new option for relapsed or refractory follicular lymphoma

Blood Cancers

Brexucabtagene Autoleucel Approval Changes MCL Treatment Landscape

Brexucabtagene Autoleucel Approval Changes MCL Treatment Landscape

BY GINA MAURO

Is Chemotherapy an Emergency When Fertility Is at Risk?

Is Chemotherapy an Emergency When Fertility Is at Risk?

BY STEPHANIE L. JACKSON, MSN, RN, AOCNS, BMTCN

Molecular Testing Guides Diagnosis, Treatment in Blood Cancers

Molecular Testing Guides Diagnosis, Treatment in Blood Cancers

BY BRIELLE BENYON

FDA Approves Venetoclax Combinations for Certain AML Indications

FDA Approves Venetoclax Combinations for Certain AML Indications

BY BRIELLE BENYON

Nurses' Role in Cardiotoxicity in Cancer Survivors

Nurses' Role in Cardiotoxicity in Cancer Survivors

BY BRIELLE BENYON

$FDA Approves Pembrolizumab for Relapsed/Refractory Classical Hodgkin Lymphoma$

FDA Approves Pembrolizumab for Relapsed/Refractory Classical Hodgkin Lymphoma

BY BRIELLE BENYON

CAR T-Cell Therapy: High Response Rates, High Toxicity Rates

CAR T-Cell Therapy: High Response Rates, High Toxicity Rates

BY BRIELLE BENYON

Frontline Treatment Decisions Are Crucial in Myeloma

Frontline Treatment Decisions Are Crucial in Myeloma

BY BRIELLE BENYON

BTK Inhibitors in B-Cell Malignancies

BTK Inhibitors in B-Cell Malignancies

Cardiac Toxicities Are Common in the Blood Cancer Space

Cardiac Toxicities Are Common in the Blood Cancer Space

BY BRIELLE BENYON

External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc

OncNurse Resources

Newsroom
Continuing Education
Discussions
Web Exclusives

About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions

Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.